Literature DB >> 28826374

Coffee, Caffeine, and Health Outcomes: An Umbrella Review.

Giuseppe Grosso1,2, Justyna Godos1,3, Fabio Galvano3, Edward L Giovannucci4,5,6.   

Abstract

To evaluate the associations between coffee and caffeine consumption and various health outcomes, we performed an umbrella review of the evidence from meta-analyses of observational studies and randomized controlled trials (RCTs). Of the 59 unique outcomes examined in the selected 112 meta-analyses of observational studies, coffee was associated with a probable decreased risk of breast, colorectal, colon, endometrial, and prostate cancers; cardiovascular disease and mortality; Parkinson's disease; and type-2 diabetes. Of the 14 unique outcomes examined in the 20 selected meta-analyses of observational studies, caffeine was associated with a probable decreased risk of Parkinson's disease and type-2 diabetes and an increased risk of pregnancy loss. Of the 12 unique acute outcomes examined in the selected 9 meta-analyses of RCTs, coffee was associated with a rise in serum lipids, but this result was affected by significant heterogeneity, and caffeine was associated with a rise in blood pressure. Given the spectrum of conditions studied and the robustness of many of the results, these findings indicate that coffee can be part of a healthful diet.

Entities:  

Keywords:  caffeine; cancer; cardiovascular disease; coffee; diabetes; neurodegenerative disease

Mesh:

Substances:

Year:  2017        PMID: 28826374     DOI: 10.1146/annurev-nutr-071816-064941

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  111 in total

1.  Life-course approaches to investigate adverse effects of caffeine.

Authors:  Sylvia H Ley
Journal:  Am J Clin Nutr       Date:  2019-06-01       Impact factor: 7.045

Review 2.  Coffee Drinking and Reduced Risk of Liver Cancer: Update on Epidemiological Findings and Potential Mechanisms.

Authors:  Manami Inoue; Shoichiro Tsugane
Journal:  Curr Nutr Rep       Date:  2019-09

3.  Comment on: "Health Benefits of Light-Intensity Physical Activity: A Systematic Review of Accelerometer Data of the National Health and Nutrition Examination Survey (NHANES)".

Authors:  Juan Pablo Rey-López
Journal:  Sports Med       Date:  2018-03       Impact factor: 11.136

4.  Habitual coffee consumption and changes in measures of adiposity: a comprehensive study of longitudinal associations.

Authors:  S C Larsen; M-Lk Mikkelsen; P Frederiksen; B L Heitmann
Journal:  Int J Obes (Lond)       Date:  2017-12-21       Impact factor: 5.095

Review 5.  Mechanisms of action of coffee bioactive components on lipid metabolism.

Authors:  Renalison Farias-Pereira; Cheon-Seok Park; Yeonhwa Park
Journal:  Food Sci Biotechnol       Date:  2019-08-12       Impact factor: 2.391

Review 6.  Impacts of Caffeine during Pregnancy.

Authors:  Jingjing Qian; Qi Chen; Sean M Ward; Enkui Duan; Ying Zhang
Journal:  Trends Endocrinol Metab       Date:  2019-12-06       Impact factor: 12.015

7.  Caffeine consumption during early pregnancy impairs oviductal embryo transport, embryonic development and uterine receptivity in mice.

Authors:  Jingjing Qian; Yunfang Zhang; Yongcun Qu; Liwen Zhang; Junchao Shi; Xudong Zhang; Shichao Liu; Bo Hyun Kim; Sung Jin Hwang; Tong Zhou; Qi Chen; Sean M Ward; Enkui Duan; Ying Zhang
Journal:  Biol Reprod       Date:  2018-12-01       Impact factor: 4.285

8.  Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers.

Authors:  Youngyo Kim; Youjin Je; Edward Giovannucci
Journal:  Eur J Epidemiol       Date:  2019-05-04       Impact factor: 8.082

9.  Caffeine Prevents Memory Impairment Induced by Hyperhomocysteinemia.

Authors:  Karem H Alzoubi; Nizar M Mhaidat; Emad A Obaid; Omar F Khabour
Journal:  J Mol Neurosci       Date:  2018-08-23       Impact factor: 3.444

10.  Higher habitual dietary caffeine consumption is related to lower experimental pain sensitivity in a community-based sample.

Authors:  Demario S Overstreet; Terence M Penn; Sarah T Cable; Edwin N Aroke; Burel R Goodin
Journal:  Psychopharmacology (Berl)       Date:  2018-09-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.